Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Up – Should You Buy?

Bio-Rad Laboratories, Inc. (NYSE:BIO.BGet Free Report)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $325.60, but opened at $341.00. Bio-Rad Laboratories shares last traded at $341.00, with a volume of 309 shares.

Bio-Rad Laboratories Stock Up 4.7 %

The company has a market cap of $9.55 billion, a P/E ratio of -12.48 and a beta of 0.72. The company has a quick ratio of 4.52, a current ratio of 6.14 and a debt-to-equity ratio of 0.16. The firm has a fifty day moving average price of $333.82 and a 200 day moving average price of $322.15.

About Bio-Rad Laboratories

(Get Free Report)

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.

Featured Stories

Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.